Mahmut Akpek

Mahmut Akpek

Auto-generated profile, based on publicly available information

Mahmut Akpek

Department of Cardiology, Kayseri Education and Research Hospital, Kayseri, Turkey

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2014 in European Journal of Heart Failure
Verified
Journal Article
Closed access
PDF file
MAMahmut Akpek
Mahmut Akpek
IOIbrahim Ozdogru
Ibrahim Ozdogru
OSOmer Sahin
Omer Sahin
MIMevlude Inanc
Mevlude Inanc
ADAli Dogan
Ali Dogan
AEAli Ergin
Ali Ergin

10 December 2021 in Angiology
Verified
Journal Article
Closed access
PDF file
MAMahmut Akpek
Mahmut Akpek
The coronavirus disease 2019 (COVID-19) outbreak remains a major public health challenge worldwide. The present study investigated the effect of COVID-19 on blood pressure (BP) during short term follow-up. A total of 211 consecutive COVID-19 patients who were admitted to Parkhayat Kutahya hospital were retrospectively screened. Information was obtained from the electronic medical records and National health data registry. The study outcome was new onset of hypertension according to the Eight Joint National Committee and European Society of Cardiology Guidelines. Finally, 153 confirmed COVID-19 patients (mean age 46.5 ± 12.7 years) were enrolled. Both systolic (120.9 ± 7.2 vs 126.5 ± 15.0 mmHg, P <.001) and diastolic BP (78.5 ± 4.4 vs 81.8 ± 7.4 mmHg, P <.001) were significantly higher in the post COVID-19 period than on admission. New onset hypertension was observed in 18 patients at the end of 31.6 ± 5.0 days on average (P <.001). These findings suggest that COVID-19 increases systolic and diastolic BP and may cause new onset hypertension.

31 January 2013 in Angiology
Verified
Journal Article
Closed access
TCTurgay CELIK
Turgay CELIK
MKMehmet G. Kaya
Mehmet G. Kaya
MAMahmut Akpek
Mahmut Akpek
MYMikail Yarlioglues
Mikail Yarlioglues
BSBahadir Sarli
Bahadir Sarli
CGCharles Michael Gibson
Charles Michael Gibson
We evaluated the association of total bilirubin with post-percutaneous coronary intervention (PCI) coronary blood flow and in-hospital major adverse cardiac events (MACEs) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI. A total of 536 consecutive patients with STEMI (male 79%, mean age = 59.9 ± 12.6 years) admitted within 6 hours from symptom onset were enrolled. Patients were divided into 2 groups based on the thrombolysis in myocardial infarction (MI) flow grade. In-stent thrombosis, nonfatal MI, and in-hospital mortality were significantly higher in no-reflow group (P = .007, P = .002, and P < .001, respectively). On multivariate regression, the total bilirubin levels remained independent predictors of no-reflow (odds ratio [OR] 1.586, 95% confidence interval [CI] 1.02-2.47; P = .042) and in-hospital MACE (OR 1.399, 95% CI 1.053-1.857; P = .020). Serum bilirubin levels were independently associated with no-reflow and in-hospital MACE in patients with STEMI undergoing primary PCI.

9 April 2012 in Angiology
Verified
Journal Article
Closed access
OSOmer Sahin
Omer Sahin
MAMahmut Akpek
Mahmut Akpek
DEDeniz Elcik
Deniz Elcik
SKSerhat Karadavut
Serhat Karadavut
VSVedat Simsek
Vedat Simsek
MKMehmet G. Kaya
Mehmet G. Kaya
We investigated whether serum bilirubin level (a marker of heme oxygenase activity) is a predictor of high levels of SYNTAX score (SXscore) in patients with acute myocardial infarction. Patients (n = 281; male 77%; mean age 60 ± 12) who were admitted with ST-elevation myocardial infarctions (STEMIs) were enrolled. Patients were divided into 2 groups. Group 1 was defined as SXscore <22 and group 2 was defined as SXscore ≥22. Total bilirubin levels were significantly higher in the high-SXscore group than in the low-SXscore group (0.86 ± 0.42 vs 1.02 ± 0.51, P = .005). A significant correlation was detected between total bilirubin and SXscore (r = .42; P = .001). At multivariate analysis, total bilirubin (odds ratio: 1.86, 95% confidence interval 1.04-3.35; P = .038) was an independent risk factor for high SXscore in patients with STEMI. In conclusion, serum bilirubin level is independently associated with SXscore in patients with STEMI.

1 November 2010 in International Journal of Infectious Diseases
Verified
Journal Article
Closed access
OGOzgur Gunebakmaz
Ozgur Gunebakmaz
MKMehmet Gungor Kaya
Mehmet Gungor Kaya
EKEsma Gunduz Kaya
Esma Gunduz Kaya
IAIdris Ardic
Idris Ardic
MYMikail Yarlioglues
Mikail Yarlioglues
IOIbrahim Ozdogru
Ibrahim Ozdogru

5 September 2011 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
MAM. Akpek
M. Akpek
MKM. G. Kaya
M. G. Kaya
MYM. Yarlioglues
M. Yarlioglues
ODO. Dogdu
O. Dogdu
IAI. Ardic
I. Ardic
NKN. Kalay
N. Kalay
To determine the association of platelet indices with spontaneous echo contrast (SEC) in patients with mitral stenosis. A total of 232 consecutive patients with mitral stenosis who undergoing mitral balloon valvuloplasty were enrolled to the study. Patients were divided into two groups according to the formation of SEC in the left atrium. Group 1: mitral stenosis complicated with SEC; Group 2: mitral stenosis without SEC. Transthoracic echocardiography and transoesophageal echocardiography were performed for each patient. Complete blood counting parameters were measured and all routine biochemical tests were performed. There were 133 patients (mean age 42 ± 11 and 74% female) in the SEC(-) group and 99 patients (mean age 45 ± 10 and 64% female) in the SEC(+) group. Plateletcrit (0.25 ± 0.06 vs. 0.27 ± 0.07, P = 0.043) and mean platelet volume (MPV) levels (9.4 ± 1.1 vs. 10.4 ± 1.2, P < 0.001) were significantly higher in the SEC(+) group. When we divided the SEC(+) patients into four subgroups according to previously reported criteria, MPV levels increased to correlate with the degree of SEC (P < 0.001). At multivariate analysis, MPV levels [odds ratio (OR) 2.365, 95% confidence interval (CI) 1.720-3.251; P < 0.001] and PCT levels (OR 2.699, 95% CI 1.584-4.598; P= 0.033) are independent risk factors of SEC in patients with mitral stenosis. In patients with mitral stenosis, cheaply and easily measurable platelet indices including MPV and PCT levels are associated with the presence of SEC and are independent risk factors of SEC.